![Matt Arens](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Matt Arens
Directeur/Membre du Conseil chez
HEALTH CATALYST, INC.
Fortune : 4 M $ au 30/06/2026
Profil
Matthew Paul Arens is the founder of First Light Asset Management LLC, founded in 2013, serving as CEO & Senior Portfolio Manager.
Current job includes Independent Director at Health Catalyst, Inc. starting in 2025.
Former jobs include Independent Director at Societal CDMO, Inc. from 2023 to 2024, and President & Senior Portfolio Manager at Kopp Investment Advisors LLC from 2012 to 2013.
Education includes undergraduate studies at Purdue University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
NeoGenomics, Inc.
 NeoGenomics, Inc. Medical/Nursing ServicesHealth Services Provides genetic and molecular testing services 0,15% | 30/04/2026 | 200 000 ( 0,15% ) | 3 M $ | 30/06/2026 |
Organogenesis Holdings, Inc.
 Organogenesis Holdings, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and commercializes regenerative medicines products for the advanced wound care and surgical and sports medicine markets 0,18% | 31/12/2025 | 231 000 ( 0,18% ) | 561 330 $ | 30/06/2026 |
KORU Medical Systems, Inc.
 KORU Medical Systems, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and distributes portable medical devices 0,19% | 31/12/2025 | 88 167 ( 0,19% ) | 370 301 $ | 30/06/2026 |
Postes actifs de Matt Arens
| Sociétés | Poste | Début |
|---|---|---|
| HEALTH CATALYST, INC. | Directeur/Membre du Conseil | 01/12/2025 |
First Light Asset Management LLC
 First Light Asset Management LLC Investment ManagersFinance First Light manages a long-only health care equity investment strategy (the Genesis Strategy) for separate account clients. The Genesis Strategy utilizes a fundamental, bottom-up approach to stock selection to primarily seek out high quality, reasonably priced, growth-equity opportunities among publicly traded micro to small/mid-cap health care and life sciences companies. | Directeur Général | 01/09/2013 |
Anciens postes connus de Matt Arens
| Sociétés | Poste | Fin |
|---|---|---|
| SOCIETAL CDMO, INC. | Directeur/Membre du Conseil | 08/04/2024 |
Kopp Investment Advisors LLC
 Kopp Investment Advisors LLC Investment ManagersFinance Kopp Investment Advisors offers two main investment strategies: Emerging Growth and Total Quality Management (TQM). In general, the firm tends to invest in the stocks of US micro-cap and small-cap companies in the electronic technology and health technology and distribution services sectors. Kopp Investment Advisors maintains a low turnover rate. The firm's Emerging Growth strategy focuses on investments in growing small-cap companies primarily in the technology and healthcare sectors. Kopp Investment Advisors' TQM strategy focuses on investments in quality-advantaged large-cap companies. The strategy scores S&P 500 companies relative to their peers based on their successful use of quality as the means to gain competitive advantage. TQM portfolios are invested in the highest scoring companies from a cross section of economic sectors and industry groups within the S&P 500. The firm also offers blended portfolios that provide diversification across market-caps and investment styles. The TQM Blend portfolio invests 30% in companies that are identified through Kopp Investment Advisors' Emerging Growth strategy and 70% in companies identified in their TQM strategy. The Balanced Blend portfolio invests 50% in companies identified through the firm's Emerging Growth strategy and 50% in companies identified in their TQM strategy. The Emerging Blend portfolio invests 70% in companies identified through the firm's Emerging Growth strategy and 30% in companies identified in their TQM strategy. Kopp Investment Advisors' investment process begins with research received from national brokerage firms, as well as smaller regional firms. The firm further qualifies prospective investments with information from corporate contacts, trade shows and company visits. Once they have identified a list of potential companies, they review company financial data and analysts' estimates and conduct quantitative analysis. Kopp Investment Advisors looks for companies that currently generate or have the capacity to generate excess cash. In addition to reviewing financial data, the firm looks closely at companies' business plans and assesses managers based on their experience, expertise and personal integrity. When selecting companies for ongoing evaluation, Kopp Investment Advisors considers the following criteria: (1) superior earnings growth or earnings potential (2) p/e and price-to-sales ratios versus market/group multiples and (3) R&D spending. The decision to buy stocks or hold positions is determined by a variety of factors, with emphasis on appreciation potential. Once in the portfolio, stocks are reviewed on an ongoing basis. Portfolios are constructed from the firm's list that is established by the senior members of the portfolio management group. Stocks are purchased when their price is within an acceptable range. If the price moves above the range, buying stops. | President | 31/08/2013 |
Formation de Matt Arens
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
55
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Kopp Investment Advisors LLC
Kopp Investment Advisors LLC Investment ManagersFinance Kopp Investment Advisors offers two main investment strategies: Emerging Growth and Total Quality Management (TQM). In general, the firm tends to invest in the stocks of US micro-cap and small-cap companies in the electronic technology and health technology and distribution services sectors. Kopp Investment Advisors maintains a low turnover rate. The firm's Emerging Growth strategy focuses on investments in growing small-cap companies primarily in the technology and healthcare sectors. Kopp Investment Advisors' TQM strategy focuses on investments in quality-advantaged large-cap companies. The strategy scores S&P 500 companies relative to their peers based on their successful use of quality as the means to gain competitive advantage. TQM portfolios are invested in the highest scoring companies from a cross section of economic sectors and industry groups within the S&P 500. The firm also offers blended portfolios that provide diversification across market-caps and investment styles. The TQM Blend portfolio invests 30% in companies that are identified through Kopp Investment Advisors' Emerging Growth strategy and 70% in companies identified in their TQM strategy. The Balanced Blend portfolio invests 50% in companies identified through the firm's Emerging Growth strategy and 50% in companies identified in their TQM strategy. The Emerging Blend portfolio invests 70% in companies identified through the firm's Emerging Growth strategy and 30% in companies identified in their TQM strategy. Kopp Investment Advisors' investment process begins with research received from national brokerage firms, as well as smaller regional firms. The firm further qualifies prospective investments with information from corporate contacts, trade shows and company visits. Once they have identified a list of potential companies, they review company financial data and analysts' estimates and conduct quantitative analysis. Kopp Investment Advisors looks for companies that currently generate or have the capacity to generate excess cash. In addition to reviewing financial data, the firm looks closely at companies' business plans and assesses managers based on their experience, expertise and personal integrity. When selecting companies for ongoing evaluation, Kopp Investment Advisors considers the following criteria: (1) superior earnings growth or earnings potential (2) p/e and price-to-sales ratios versus market/group multiples and (3) R&D spending. The decision to buy stocks or hold positions is determined by a variety of factors, with emphasis on appreciation potential. Once in the portfolio, stocks are reviewed on an ongoing basis. Portfolios are constructed from the firm's list that is established by the senior members of the portfolio management group. Stocks are purchased when their price is within an acceptable range. If the price moves above the range, buying stops. | Finance |
Purdue University
 Purdue University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Societal CDMO, Inc.
 Societal CDMO, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage pharmaceutical company | Health Technology |
Health Catalyst, Inc.
 Health Catalyst, Inc. Packaged SoftwareTechnology Services Provides cloud-based data platform, analytics software application and professional services for healthcare industry | Technology Services |
First Light Asset Management LLC
First Light Asset Management LLC Investment ManagersFinance First Light manages a long-only health care equity investment strategy (the Genesis Strategy) for separate account clients. The Genesis Strategy utilizes a fundamental, bottom-up approach to stock selection to primarily seek out high quality, reasonably priced, growth-equity opportunities among publicly traded micro to small/mid-cap health care and life sciences companies. | Finance |
